Skip to main content

Day: September 28, 2020

HOYLU AB: HOYLU ADDS WORKSPACE VOTING AND TIMER FEATURES

Stockholm, Sweden, September 28, 2020 – Hoylu, a leader in visual collaboration solutions for distributed teams, announced today the immediate addition of two powerful new features to Hoylu workspaces for all users. Voting and Timer are available now to all registered users of Hoylu, and expand functionality for new and existing workspaces.Available as part of every workspace, users can now place votes using emojis, icons and symbols on notes and tasks. This functionality enhances project planning, retrospectives, brainstorming and task management by offering engaging user participation that can help guide workplace decisions. Voting objects are fully flexible and quickly tallies items for ease of use by project managers or workspace owners.The timer functionality allows synchronization of tasks and projects by allowing users to add a...

Continue reading

HOYLU AB: HOYLU LÄGGER TILL RÖSTNING OCH TIMER FUNKTIONER I ARBETSYTORNA

Stockholm, Sverige, 28 september 2020 – Hoylu, ledande inom visuella samarbetslösningar för distribuerade team, tillkännagav idag det omedelbara tillskottet av två kraftfulla nya funktioner i Hoylu-workspaces för alla användare. Voting (röstning) och Timer är tillgängliga nu för alla registrerade Hoylu-användare, och utökar därmed funktionaliteten för nya och befintliga arbetsytor.Timerfunktionen tillåter synkronisering av uppgifter och projekt genom att användarna kan lägga till en flexibel timer till alla arbetsytor som räknar ned till en deadline för alla användare. Timers kvarstår utanför aktiv användning, vilket gör det effektivt om kort eller lång tid ska brukas, eller helt enkelt att sätta en tidsram för en specifik uppgift för att uppnå effektivitet.För att se en video om denna nya funktionalitet, besök Hoylu videokanal eller...

Continue reading

SCOR welcomes A.M. Best’s decision to confirm its Financial Strength Rating of ‘A+ Superior’ and its Issuer Credit Rating of ‘aa-’

Press ReleaseSeptember 28, 2020 – N° 21SCOR welcomes A.M. Best’s decision to confirm itsFinancial Strength Rating of ‘A+ Superior’and its Issuer Credit Rating of ‘aa-’A.M. Best has decided to affirm SCOR’s Financial Strength Rating of ‘A+ (Superior)’ and its Long-Term Issuer Credit Rating of ‘aa-’.According to A.M. Best, this decision reflects “SCOR’s balance sheet strength, which A.M. Best categorises as very strong, as well as its strong operating performance, very favourable business profile and very strong enterprise risk management.”Indeed, A.M. Best recognises that “SCOR’s balance sheet strength is underpinned by risk-adjusted capitalisation that exceeds the level required to support the strongest assessment, as measured by Best’s Capital Adequacy Ratio.” A.M. Best expects “risk-adjusted capitalisation to be maintained at...

Continue reading

SCOR salue la décision de A.M. Best de confirmer la note de solidité financière du Groupe à « A+ (Supérieure) » et sa note de crédit émetteur à « aa- »

Communiqué de presse28 septembre 2020 – N° 21SCOR salue la décision de A.M. Best de confirmer la note de solidité financière du Groupe à « A+ (Supérieure) » et sa note de crédit émetteur à « aa- »L’agence A.M. Best a décidé de confirmer la note de solidité financière du groupe SCOR à « A+ (Supérieure) » et sa note de crédit émetteur à « aa- ».Pour A.M. Best, cette décision reflète : « la solidité du bilan de SCOR, jugée très élevée, ainsi qu’une performance opérationnelle forte, un fonds de commerce très solide et un risk management de très haut niveau ».A.M. Best reconnaît que « la solidité du bilan de SCOR est confortée par un niveau de capital ajusté du risque – mesuré par le ratio de capitalisation Best’s Capital Adequacy Ratio – qui se situe au niveau le plus élevé ». A.M. Best anticipe que « le niveau de capital ajusté du...

Continue reading

Victory Square Technologies Portfolio Company receives an order of Safetest Covid-19 Testing Kits from North America’s TM Safety Supplies Company

Victory Square Health Receives an order of 2,000,000 units of Safetest Covid-19 Testing Kits subject to Health Canada approvalVictory Square Health to be exclusive supplier of its proprietary Safetest products to TM Safety Supplies of CanadaThis order and potential subsequent orders is subject to Health Canada approvalTM Safety Supplies is a North American supplier of health and safety equipment including PPE protection to some of North America’s largest manufacturers. Based in Toronto, Ontario, TM Safety Supplies clients include Nestle, CIBC Bank, and Sysco to name a fewVANCOUVER, British Columbia, Sept. 27, 2020 (GLOBE NEWSWIRE) — Victory Square Health Inc. (“VS Health” or the “Company”) – a portfolio company of Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased...

Continue reading

WCP B Move Update: Plant Relocated Safely to Pilivili

Kenmare Resources plc (“Kenmare” or “the Company”)28 September 2020WCP B Move Update: Plant Relocated Safely to PiliviliKenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium minerals and zircon, which operates the Moma Titanium Minerals Mine in northern Mozambique, is pleased to announce that Wet Concentrator Plant (“WCP”) B has been relocated safely to Pilivili.Kenmare previously announced three development projects that together have the objective of increasing annual ilmenite production to 1.2 million tonnes (plus co-products) on a sustainable basis from 2021. The move of WCP B to the high grade Pilivili ore zone is the final of the three projects. This increased production is expected to significantly lower cash operating costs to between US$125 and US$135 per tonne (in 2020 real terms). Consequently,...

Continue reading

Exercise of Warrants

Providence Resources P.l.c.Exercise of WarrantsDublin and London – 28 September 2020 – Providence Resources P.l.c. (PVR LN, PRP ID), the Irish based resource development company (“Providence” or the “Company”), announces that 16,433,333 warrants of 3p each have been exercised raising £492,999.99 for the Company. The warrants were issued as part of the fundraising in May 2020.Providence Resources has issued a total of 16,433,333 new Ordinary Shares (the “New Ordinary Shares

Continue reading

ArcelorMittal unlocks value through separation of integrated US assets and repositions its footprint in North America

 28 September 2020, 07:45 CETArcelorMittal (the “Company”, “Group”) announces it has entered into a definitive agreement (the “Agreement”) with Cleveland-Cliffs Inc. (“Cleveland-Cliffs”) pursuant to which Cleveland-Cliffs will acquire 100% of the shares of ArcelorMittal USA (the “Transaction”) for a combination of cash and stock.                                                 Transaction HighlightsUnder the terms of the agreement, ArcelorMittal expects to receive an aggregate equity value consideration of $1.4 billion upon closing of the Transaction. Approximately one third of the consideration is in upfront cash ($505 million). The remaining two thirds of the consideration is in the form of equity:                                                                                                   stock component of approximately 78 million...

Continue reading

Yleiselektroniikan yhteistoimintaneuvottelut Suomessa päätökseen

YLEISELEKTRONIIKKA OYJ              Sisäpiiritieto 28.9.2020 klo 08:30Yleiselektroniikan yhteistoimintaneuvottelut Suomessa päätökseenYleiselektroniikka- konserni on saanut päätökseen 11.8.2020 käynnistetyt yhteistoimintaneuvottelut. Neuvottelut koskivat Yleiselektroniikka Oyj:n ja Machinery Oy:n koko Suomen henkilöstöä, yhteensä noin 140 henkilöä, ja ne käynnistettiin liiketoimintojen ja organisaation uudelleenjärjestelemiseksi sekä toimintojen tehostamiseksi. Suunniteltujen toimenpiteiden ilmoitettiin johtavan arviolta 30 henkilön vähennystarpeeseen.Päättyneiden neuvottelujen seurauksena irtisanotaan enintään 23 henkilöä vuoden 2020 loppuun mennessä. Irtisanomisten lisäksi konsernista vähenee seitsemän positiota muun muassa neuvottelujen aikana tapahtuneiden irtisanoutumisten ja eläköitymisten seurauksena.YT- neuvottelut olivat osa...

Continue reading

Basilea starts phase 1/2 study FIDES-03 with derazantinib in patients with gastric cancer

Basel, Switzerland, September 28, 2020Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has initiated the phase 1/2 study, FIDES-03, with the FGFR inhibitor derazantinib. The multi-cohort study is evaluating derazantinib in patients with advanced gastric cancer with FGFR genetic aberrations. Derazantinib will be assessed as monotherapy and in combination with other cancer treatments, for instance with Roche’s PD-L1 checkpoint inhibitor, atezolizumab.Basilea will be the sponsor of the study and Roche will provide clinical supply of atezolizumab.Dr. Marc Engelhardt, Basilea’s Chief Medical Officer, said: “Our development strategy for derazantinib is focused on strengthening the clinical evidence on the differentiation versus other FGFR inhibitors. The unique kinase inhibition profile of derazantinib, results from preclinical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.